I would like to officially announce that Chemist Warehouse has signed an agreement to acquire Astrid. With Chemist Warehouse’s backing, we are able to supercharge Astrid’s growth, meaning:
- We will make your medicines more accessible
- We can build more Astrid’s closer to you
- We can grow our clinical care teams
- We will continue to improve access, education and advocacy
These are things we simply couldn’t achieve at scale on our own.
Truth is, medicinal cannabis continues to be one of the most highly regulated and resource-intensive industries in Australia. To continue providing ethical, elevated care – and to expand that care to more patients – we needed a partner who understood our vision, and could support our growth.
I want to be clear: Astrid’s values are not changing. Our patient-first approach, our commitment to integrity, our advocacy – all of this remains at the heart of what we do.
This is our opportunity to break the stigma in a meaningful way: cannabis could become a more accepted medicine with scale, with visibility, with investment, and with a team that continues to advocate loudly and unapologetically on behalf of our patients.
I am grateful to remain as CEO and will continue to lead Astrid with the same purpose and responsibility I always have. Your care remains the priority. The heart of Astrid isn’t going anywhere.
What this means for our community
I understand why this news may be unexpected. Astrid is personal — to me, to our staff, and to many of you who have trusted us with your health and your stories. That trust means everything.
Astrid is still Astrid — with the same heart, the same standards, and the same commitment to doing things the right way.
Thank you for trusting us with your health — that trust is something I will always protect.
We’re staying true to who we are.
We’re just gaining the support to reach more people who may need us.
Warmest,
Lisa Nguyen
Founder & CEO, Astrid
Published 12/12/2025.
